Subtle changes in individual joints result in both positive and negative change scores in a patient: results from a clinical trial in patients with rheumatoid arthritis

por Lukas, C, Landewé, R, Fatenejad, S, van der Heijde, D
Publicado 2008

Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial

por van der Heijde, D, Landewé, R, van Vollenhoven, R, Fatenejad, S, Klareskog, L
Publicado 2008

Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor in...

por Feist, Eugen, Fatenejad, Saeed, Grishin, Sergey, Korneva, Elena, Luggen, Michael E, Nasonov, Evgeniy, Samsonov, Mikhail, Smolen, Josef S, Fleischmann, Roy M
Publicado 2022

Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy an...

por Nasonov, Evgeniy, Fatenejad, Saeed, Feist, Eugen, Ivanova, Mariana, Korneva, Elena, Krechikova, Diana G, Maslyanskiy, Aleksey L, Samsonov, Mikhail, Stoilov, Rumen, Zonova, Elena V, Genovese, Mark
Publicado 2022

Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised...

por Combe, B, Codreanu, C, Fiocco, U, Gaubitz, M, Geusens, P P, Kvien, T K, Pavelka, K, Sambrook, P N, Smolen, J S, Khandker, R, Singh, A, Wajdula, J, Fatenejad, S
Publicado 2008